We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$709M
AUM Growth
+$29.4M
Cap. Flow
+$90.1M
Cap. Flow %
12.71%
Top 10 Hldgs %
39.27%
Holding
116
New
17
Increased
23
Reduced
16
Closed
10

Top Buys

Rank Stock Value
1
EQRX
EQRx, Inc. Common Stock
EQRX
+$21.6M
2
NTLA icon
Intellia Therapeutics
NTLA
+$15.4M
3
AVDL
Avadel Pharmaceuticals
AVDL
+$13.4M
4
NVCR icon
NovoCure
NVCR
+$11.3M
5
QURE icon
uniQure
QURE
+$8.42M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$10.9M
2
COF icon
Capital One
COF
+$8.75M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.67M
4
PYXS icon
Pyxis Oncology
PYXS
+$4.58M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 94.04%
2 Financials 5.11%
3 Real Estate 0.78%
4 Consumer Discretionary 0.07%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XERS icon
101
Xeris Biopharma Holdings
XERS
$1.45B
$279K 0.04%
+150,000
New +$344K
STIM icon
102
Neuronetics
STIM
$166M
$270K 0.04%
200,000
– –
PASG icon
103
Passage Bio
PASG
$14.1M
$263K 0.04%
20,000
+5,000
+33% +$82.1K
WGS icon
104
GeneDx Holdings
WGS
$2.3B
$232K 0.03%
63,636
– –
TLPH icon
105
Talphera
TLPH
$74.2M
$113K 0.02%
195,000
– –
RNAZ icon
106
TransCode Therapeutics
RNAZ
$4.19M
$42.2K 0.01%
+2
New +$126K
AMLX icon
107
Amylyx Pharmaceuticals
AMLX
$2.54B
– –
-100,000
Closed -$2.16M
BKU icon
108
Bankunited
BKU
$3.36B
– –
-100,000
Closed -$2.15M
COF icon
109
Capital One
COF
$134B
– –
-80,000
Closed -$8.75M
CREG
110
DELISTED
Smart Powerr
CREG
– –
-1,251
Closed -$203K
CRSP icon
111
CRISPR Therapeutics
CRSP
$5.17B
– –
-20,000
Closed -$1.12M
PHAT icon
112
Phathom Pharmaceuticals
PHAT
$692M
– –
-250,000
Closed -$3.58M
PYXS icon
113
Pyxis Oncology
PYXS
$236M
– –
-1,787,775
Closed -$4.58M
TSVT
114
DELISTED
2seventy bio
TSVT
– –
-250,000
Closed -$2.53M
FRLN
115
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-100,000
Closed -$258K
PRDS
116
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-1,945,206
Closed -$3.52M
1 2 3 4
5

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return

Tang Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Tang Capital Management held 116 positions worth $709M, up 4.3% from $679M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tang Capital Management deployed $90.1M of net new capital in Q3 2023, opening 17 new positions and adding to 23 existing holdings. Its largest new stake was EQRx, Inc. Common Stock: 10,086,110 shares worth $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was bluebird bio, an estimated $10.9M trimmed.

  • Tang Capital Management's largest Q3 2023 buy was EQRx, Inc. Common Stock: 10,086,110 shares worth $22.4M.
  • Tang Capital Management added most to NovoCure in Q3 2023, an estimated $11.3M increase.
  • Tang Capital Management's biggest Q3 2023 reduction was bluebird bio, cutting an estimated $10.9M.
  • Tang Capital Management fully exited Capital One in Q3 2023, selling an estimated $8.75M.
  • Tang Capital Management's ten largest holdings make up 39% of its $709M portfolio in Q3 2023.
  • Tang Capital Management opened 17 new positions and closed 10 in Q3 2023.
  • Tang Capital Management's portfolio value rose 4.3% quarter-over-quarter to $709M.

Based on Tang Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.